These data are consistent with the fact that SFRP1, SFRP2 and SFRP5 suppress Wnt-dependent transcription by 60%, decrease c-myc mRNA expression, inhibit in vitro tumor growth and induce cell death in CRC cells carrying oncogenic mutations of β−catenin [15]. The gene discussed is MYC; the disease is neoplasm.